Literature DB >> 25308701

Effect of dose-rate and irradiation geometry on the biological response of normal cells and cancer cells under radiotherapeutic conditions.

K Ślosarek1, M Konopacka2, J Rogoliński3, A Sochanik2.   

Abstract

Biological efficacy of radiation depends on its energy, dose, dose rate, and on the type of cell irradiated. Changes in the radiation-energy spectrum due to passage through absorbing and scattering media affect the variability of biological responses of the cells. We investigated the impact of photon-radiation dose rate on the biological response of both normal and cancer cells in culture exposed to radiation in various positions (relative to the axis of the radiation beam) and depth of the absorbing medium (water). Human cancer cells (A549 and HCT116) as well as normal human cells (BEAS-2B) were placed in a water phantom at different medium depths (3 cm, 15 cm) and exposed to 6-MV photon radiation delivered at a beam rate of either 100 or 600 MU/min (Monitor Units per minute). The applied dose was 5 Gy. Cells were exposed in the axis and four cm outside the radiation field. Radiation-induced genetic changes were estimated as frequency of micro-nucleated and apopototic-like cells, by use of a cytokinesis-block micronucleus test. A smaller dose rate induced more severe cytogenetic damage (formation of micro-nucleated and apoptotic cells) than a higher dose rate, both in normal and in cancer cells. More micro-nucleated and apoptotic cells were formed at larger depth than at smaller depth. This holds true for both the normal and the two types of cancer cell investigated. The extent of cytogenetic damage arising in cells placed outside the irradiation field is independent of positioning depth and dose rate. Exposure of cells to smaller dose rates and larger depths in water medium resulted in a better ratio of cytogenetic damage to cancer cells irradiated in the beam axis vs damage to normal cells exposed outside the radiation field.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Dose rate; Efficacy quotient; Irradiation geometry; Micronuclei

Mesh:

Year:  2014        PMID: 25308701     DOI: 10.1016/j.mrgentox.2014.07.005

Source DB:  PubMed          Journal:  Mutat Res Genet Toxicol Environ Mutagen        ISSN: 1383-5718            Impact factor:   2.873


  6 in total

1.  Dependence of micronuclei assay on the depth of absorbed dose.

Authors:  Seyed Mohammad Mahdi Abtahi; Seyed Mahmoud Reza Aghamiri; Masoumeh Yadolahi; Aziz Mahmoudzadeh
Journal:  Rep Pract Oncol Radiother       Date:  2017-09-17

2.  Ex Vivo Irradiation of Lung Cancer Stem Cells Identifies the Lowest Therapeutic Dose Needed for Tumor Growth Arrest and Mass Reduction In Vivo.

Authors:  Caterina Puglisi; Raffaella Giuffrida; Giuseppina Borzì; Salvatore Illari; Francesco Paolo Caronia; Paolo Di Mattia; Cristina Colarossi; Gianluca Ferini; Emanuele Martorana; Giovanni Sette; Adriana Eramo; Aurelio Lorico; Alfio Di Grazia; Stefano Forte
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

3.  Dose Rate Effects on the Selective Radiosensitization of Prostate Cells by GRPR-Targeted Gold Nanoparticles.

Authors:  Ana Marques; Ana Belchior; Francisco Silva; Fernanda Marques; Maria Paula Cabral Campello; Teresa Pinheiro; Pedro Santos; Luis Santos; António P A Matos; António Paulo
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

Review 4.  Can high dose rates used in cancer radiotherapy change therapeutic effectiveness?

Authors:  Maria Konopacka; Jacek Rogoliński; Aleksander Sochanik; Krzysztof Ślosarek
Journal:  Contemp Oncol (Pozn)       Date:  2017-01-12

5.  Radioprotective effects of lentil sprouts against X-ray radiation.

Authors:  Abbas Haghparast; Kamran Mansouri; Samane Moradi; Fatemeh Dadashi; Saeed Eliasi; Mahdi Sobhani; Kambiz Varmira
Journal:  Res Pharm Sci       Date:  2017-02

6.  Delivery of Radiation at the Lowest Dose Rate by a Modern Linear Accelerator is Most Effective in Inhibiting Prostate Cancer Growth.

Authors:  Keren Tazat; Oleg Reshetnyak; Natan Shtraus; Ifat Sayag; Nicola J Mabjeesh; Sharon Amir
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.